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Exercise is an essential component in type 1 diabetes (T1D) management yet approximately 60% of 
people with T1D do not participate in any structured exercise1. Exercise provides numerous benefits for those 
with T1D, such as improved body composition and glycemic control and a reduced risk of cardiovascular 
disease which is the leading cause of morbidity and mortality among young people with T1D2. For many with 
T1D, the fear of hypoglycemia during and following exercise is a major barrier to regular activity3,4. Exercise 
intensity and nutrient timing around exercise are assumed to be important factors in the risk of hypoglycemia in 
response to exercise, however, an understanding of their specific role is limited5. A better understanding of 
methods to mitigate the risk of hypoglycemia with exercise is imperative in engaging more people with T1D in 
regular exercise. 
 To address this critical need, we proposed to investigate the role of exercise intensity and peri-workout 
protein ingestion on the risk of hypoglycemia during and following exercise as well as the effect of exercise 
intensity on changes in glycemic control. Most individuals with T1D experience hypoglycemia within 45 minutes 
of beginning aerobic exercise and remain at an elevated risk of hypoglycemia for at least 24 hours following 
exercise5. Evidence suggests, however, that brief, high-intensity exercise such as high intensity interval 
training (HIIT) or resistance training tends to yield an increase in glycemia during and following exercise, likely 
due to an increased counter-regulatory response, and may contribute to increased glucose stability5. We 
hypothesize that intense aerobic or anaerobic exercise will lead to fewer occurrences of hypoglycemia during 
and following exercise and will contribute to greater time in range. Protein intake around exercise, a common 
strategy for the promotion of recovery, may also mitigate the risk of hypoglycemia in response to exercise6. 
Protein has been shown to increase glycemia through stimulating glucagon secretion and glucose production 
via gluconeogenesis which we hypothesize will reduce the risk of hypoglycemia during and following exercise. 
A greater understanding of these factors will help to establish potential strategies to attenuate the risk of 
hypoglycemia with exercise and empower individuals with T1D to improve their glycemic control through 
regular exercise.  To assess these factors, we will utilize data from an ongoing trial (DP3DK113358, PI Mayer-
Davis) of the effects of 3 different dietary patterns on glycemic control and weight loss among 82 overweight 
and obese young adults with T1D. We propose the following Specific Aims: 
 
Aim 1.  To establish the role of exercise intensity on the risk of hypoglycemia during and up to 4 hours 
following exercise. Heart rate and sRPE measures will be used to categorize exercise intensity.  The 
occurrence of hypoglycemia during and following exercise will be assessed via Continuous Glucose Monitor 
(CGM)data allowing the elucidation of the role exercise intensity plays on hypoglycemia risk. It is hypothesized 
that greater time in intense aerobic or anaerobic exercise equivalent to an estimated 80% VO2max (≥88% Age-
Predicted MHR or sRPE ≥8) will be associated with fewer incidences of hypoglycemia.  
  
Aim 2.  To investigate the effect of a high protein meal within 2 hours before or after exercise on the 
risk of hypoglycemia during and up to 4 hours following exercise. 24 hour dietary recalls will be utilized to 
assess usual protein intake within 2 hours before or after exercise and CGM data will be assessed to identify 
the occurrence of hypoglycemia during and following exercise.  It is hypothesized that the consumption of a 
high protein meal (≥25g protein) 2 hours prior to exercise will reduce the risk of hypoglycemia during and 4 
hours following exercise. It is also hypothesized that a high protein meal within 2 hours after exercise cessation 
will reduce the risk of hypoglycemia up to 4 hours following exercise.   
  
Aim 3. To elucidate the role of exercise intensity and peri-workout protein ingestion on glycemic 
excursions overnight and up to 24 following exercise. Heart rate and sRPE measures will be used to 
categorize exercise intensity and 24-hour dietary recalls will be used to determine protein ingestion within 2 
hours of exercise. Time in range, Time below range and time above range will be assessed via CGM data. It is 
hypothesized that greater time in intense aerobic or anaerobic exercise equivalent to an estimated 80% 
VO2max (≥88% Age-Predicted MHR or sRPE ≥8) will lead to greater time in range (70-180mg/dL) and reduced 
time below range (<70 mg/dl) overnight and 24 hours following exercise, but will also lead to greater time 
above range (181-250mg/dL). We also hypothesize that protein ingestion within 2 hours before or after 
exercise will contribute to greater time in range following exercise.   
 
The proposed study will explore promising alternatives to traditional exercise and nutrition 
recommendations for people with T1D. Preliminary data suggests that exercising at higher intensities and 
consuming protein around exercise may help to ameliorate the risk of hypoglycemia experienced by many with 
T1D, however, our knowledge of their role is incomplete. The insights from this study may help to empower 
individuals with T1D to achieve greater levels of physical activity and garner greater interest in investigating 
new alternatives to traditional exercise and nutrition strategies in the field of diabetes research.   
 
Research Strategy 
1. Significance  
1.1. Premise. Cardiovascular disease is the leading cause of mortality among young people with T1D7,8. 
Among patients with T1D, approximately 40% have hypertension, 60% have dyslipidemia and 60% are 
overweight or obese1. Physical activity plays a major role in reducing the risk of cardiovascular disease and 
other adverse health outcomes for people with T1D. A cross-sectional analysis of 18,028 adults with T1D 
found an inverse relationship between physical activity and HbA1c, diabetic ketoacidosis, BMI, dyslipidemia, 
hypertension, retinopathy or microalbuminuria, and severe hypoglycemia with coma1. 
A meta-analysis of the health benefits of physical activity for people with T1D found that regular 
exercise increased physical fitness and strength, reduced cardiovascular risk factors and daily insulin 
requirements and improved well-being in people with T1D2. They also highlighted, however, that the few 
randomized controlled trials reported have been small, of short duration and often did not control for diet and 
insulin dosing and that there was an urgent need for larger controlled trials that can provide guidance on the 
intensity, duration and type of exercise that will provide the greatest benefit for people with T1D. A further 
meta-analysis on the effects of exercise on acute and chronic glycemic control indicated that regular exercise, 
particularly aerobic exercise, contributed to better acute and chronic glycemic control in patients with T1D, 
however, there were only 2-3 studies investigating the effects of resistance training, high-intensity interval 
training or mixed training from which to calculate effect sizes for those types of exercise9.  
While there are many benefits to regular exercise in T1D, less than 20% of people with T1D report 
managing to perform aerobic exercise more than twice per week and approximately 60% report that they do 
not participate in any structured exercise1. The fear of hypoglycemia is a major barrier to exercise for many 
people with T1D3,4,10,11. Most people with T1D experience hypoglycemia within 45 minutes from the onset of 
aerobic exercise and remain at elevated risk of hypoglycemia for at least 24 hours following exercise12–15. In 
contrast, however, intense aerobic and anaerobic exercise and protein ingestion are both associated with rises 
in glycemia, however, their role in the prevention of hypoglycemia and promotion of greater time in range 
among individuals with T1D remains unclear.  
1.2. Overarching Hypothesis. Our overarching hypothesis is that in overweight or obese young adults with 
T1D, greater time spent in intense aerobic or anaerobic exercise as well higher intake of protein within 2-hours 
of exercise will result in fewer incidences of hypoglycemia and greater time in range overnight and for 24 hours 
following exercise. 
1.3. Innovation. Novel strategies are needed to equip people with T1D with the ability to overcome fear of 
hypoglycemia and to safely engage in regular exercise. Few studies have examined the effects of intense 
aerobic or anaerobic exercise on time in range and the risk of hypoglycemia. While preliminary data suggest 
an attenuated decrease in glycemia during and acutely following exercise with the inclusion of intense aerobic 
and anaerobic exercise, the results on the effects of intensity of exercise on nocturnal hypoglycemia remains 
mixed indicating the need for further research5,9,16–22. Furthermore, while protein ingestion has been shown to 
have a delayed post-prandial hyperglycemic effect and has been shown to be protective against hypoglycemia, 
however, to our knowledge no studies have been conducted on the effects of protein timing around exercise on 
time in range and the risk of post-exercise hypoglycemia in people with T1D.  
1.4 Aim 1 and Aim 3a Exercise Intensity on Glycemic Excursions. Aerobic exercise causes a decrease in 
glycemia in people with T1D with most experiencing hypoglycemia within 45 minutes of beginning aerobic 
exercise and remaining at elevated risk of hypoglycemia for at least 24 hours following exercise12–15. The 
incorporation of brief, high intensity exercise, such as resistance training or high intensity interval training 
(HIIT), has been proposed as a means of promoting improvements in cardiometabolic health while reducing 
the risk of hypoglycemia following exercise22. Resistance exercise and high intensity interval training have both 
been associated with better glucose stability and attenuated decreases in glycemia during and acutely 
following exercise compared to moderate intensity aerobic23–25.  Furthermore, inclusion of brief, high intensity 
intervals or resistance training prior to aerobic exercise has been shown to reduce the decline in blood glucose 
associated following aerobic exercise26,27. While the finds on acute changes in glycemia are promising, the 
effects of intense aerobic or anaerobic exercise on the risk of nocturnal hypoglycemia has been mixed with 
studies some studies indicating a possible protective effect18,19,25 and suggesting an increased risk of 
hypoglycemia at increased intensities of exercise 20,28. As such, we plan to investigate the effects of increasing 
exercise intensity on both acute (during and 4 hours following exercise) and delayed glycemic excursions 
(overnight and 24 hours following exercise). Overall, intense aerobic and anaerobic exercise are associated 
with increased glycemia for hours following exercise, likely contributable to an increased catecholamine 
response to higher intensity exercise5. It is our hypothesis that greater time spent in intense aerobic or 
anaerobic exercise will yield greater time in range and a reduced risk of hypoglycemia during and up to 24 
hours following exercise.  
1.5 Aim 2 and Aim 3b Protein Ingestion on Glycemic Excursion. Peri-workout protein ingestion has been 
shown to have many benefits. Protein ingestion following endurance training has been associated with reduced 
myofibrillar damage and reduced muscle soreness, greater effects seen when included as a protein 
carbohydrate mix29–32. Furthermore, resistance exercise has been shown to enhance muscle amino acid 
sensitivity of myofibrillar protein synthesis (MPS) following exercise reaching a peak around 3 hours post 
exercise and remaining elevated for 24-72 hours after33. Protein ingestion during this time of increased muscle 
sensitivity has has shown to increase MPS by 30 – 100% providing a positive muscle protein balances32. Meta-
analyses on the effects of pooled data on protein supplementation of 15-25g following exercise have found 
significant improvements in muscular strength and performance when paired with resistance exercise32,34,35. 
Protein ingestion paired with resistance exercise may also yield greater improvements in muscle mass and 
greater reductions in fat mass when paried with a hypercaloric or hypocaloric diet, respectively32,34,36–42. 
Current recommendations for post-workout protein ingestion to maximize the protein synthetic response to 
exercise are approximately 0.25g/kg or an absolute intake of 20-40g protein32. In addition to the improved 
adaptations to exercise outlined, peri-workout protein intake may also promote improved glycemic control for 
individuals with T1D. Intensive insulin therapy, an essential part of diabetes management, utilizes algorithms 
based solely on carbohydrate intake43. While carbohydrates are the predominate macronutrient affecting post-
prandial blood glucose, protein and fat have also been shown to contribute to post-prandial increases in 
glycemia6,43,44. In healthy populations, protein intake is associated with concurrent increases in insulin and 
glucagon, but not blood glucose. In T1D, however, protein stimulates increased hepatic glucose production 
that is not counteracted by a simultaneous increase in insulin secretion thus leading to increased glycemia and 
insulin requirements6. In children with T1D, meals high in protein or fat where found to increase post-prandial 
blood glucose from 3 hours to 5 hours post-meal and the effects of the macronutrients were found to be 
additive43. Protein ingestion in this study was also found to be protective against hypoglycemia43. Similarly, in 
adults with T1D, the ingestion of meals containing between 28g and 57g of additional protein have yielded 
similar post-prandial glycemic responses and insulin requirements45,46. Furthermore, the ingestion of 28g of 
protein in a mixed meal or 75g of protein alone have been shown to result in significant and sustained 
hyperglycemia commencing 2-3 hours following exercise and continuing beyond 5 hours6,44,47. It is clear that 
protein ingestion plays a role in post-prandial glycemic excursions, however, how timing of protein ingestion 
around exercise may alter time in range and the risk of exercise-induced hypoglycemia has yet to be 
investigated. We hypothesize that ingestion of a high protein meal within 2 hours prior of exercise will yield a 
reduced risk of hypoglycemia during exercise and the consumption of a high protein meal within 2 hours prior 
or following exercise will lead to greater time in range following exercise and a reduce risk of hypoglycemia up 
to 24 hours following exercise.  
1.6 Summary of Significance. Our study is highly in innovative in that it would be the first study to investigate 
the role of peri-workout protein ingestion on time in range and the risk of hypoglycemia following exercise. It 
also addresses an urgent need for greater information on the role of exercise intensity on glycemic control and 
risk of hypoglycemia during and following exercise. We expect that greater intensity of aerobic or anaerobic 
exercise will contribute to a reduced risk of hypoglycemia during and following exercise (Aim 1) and greater 
glycemic control as measured by time in range (Aim 3a). Furthermore, we expect that peri-workout protein 
ingestion will similarly result in a reduced risk of hypoglycemia during and following exercise (Aim 2) and will 
result in greater time in range (Aim 3b). To our knowledge, no other studies have investigated the role of 
protein ingestion around exercise on glycemic excursions during and following exercise in T1D Furthermore, 
reviews of physical activity trials in T1D have indicated a need for greater understanding of the role of exercise 
intensity on glycemic control and the risk of hypoglycemia. Determining the role of aerobic and anaerobic 
exercise intensity and of protein intake will contribute to the development of innovative strategies to 
mitigate the risk of exercise-induced hypoglycemia and empower people with T1D to experience the 
benefits of regular exercise.  
 
2. Approach: The following sections describe: 1) the NIH-funded study called ACT1ON, 2) the pilot physical 
activity data collection effort that was added to the ACT1ON protocol midway through the study that is the 
subject of these aims, and 3) the statistical analyses proposed for this F31 training grant. 
2.1. ACT1ON study (1DP3DK113358-02, contact PI Mayer-Davis). Prior research has demonstrated 
effectiveness of various diets for co-managing weight and HbA1c in T2D; however, no T1D-specific guidelines 
exist. A rigorous adaptive design is underway to establish estimates of the effect of a diet intervention in young 
adults with overweight or obesity and T1D. The goal of this funded Sequential Multiple Assignment 
Randomized Trial is to assess acceptability and adherence to three evidence-based diets and to estimate 
effect sizes for weight and glycemia to construct a fully powered randomized controlled trial (RCT), including 
collection/analysis of measures in the funded ancillary aims.  
Methods: Following baseline data collection and a two-week run-in, participants (Total n=69, UNC-CH (40), 
Stanford (29)) are randomized to one of three diets: Mediterranean without calorie restriction,48,49 hypocaloric 
low-carbohydrate (~15-20% calories from carbohydrate),50 and hypocaloric moderate fat (~30% calories from 
fat).51 Behavioral counseling, carbohydrate counting for insulin dosing, and encouragement of physical activity 
are the same across the diets. Potential re-randomization periods are at three- and six-months; participants are 
re-randomized if the diet is unacceptable to the participant, or if glycemic (increase in HbA1c of ≥ 0.5%) or 
weight (achieving <2% body weight loss, unless “normal weight” status achieved [BMI < 25]) targets are not 
met. The intervention period is nine months. Registered dietitians conduct 18 sessions, including phone check-
ins. Dietitians are centrally trained in Motivational Interviewing and Problem Solving Skills Training. 
Inclusion/exclusion criteria and recruitment: Individuals ages 19-30 with >1 year duration of T1D, BMI 27-
39.9, and HbA1c <13% are included. Exclusion criteria: pregnant women, diagnosed eating disorder, and other 
conditions rendering participation inappropriate. 42 participants/site (3-4/month over 12 months) are recruited.  
Standardized Measurements (baseline & 3-, 6-, and 9-months post randomization): 
Glycemic control: Participants are provided with a Abbott Freestyle LibrePro continuous glucose monitor 
(CGM) which is a flash glucose monitoring system FDA approved for use by adults 18 years of age and older. 
Blinded continuous glucose monitoring (CGM) will be used to assess short-term glycemia, including frequency 
and time spent in hypoglycemia, as well as time in range, above range, and below range during the 14 day 
wear time at each measurement visit. Consistent with a report on consensus measurements of glycemia we 
define hypoglycemia as CGM-based glucose <70mg/dl for more than 10 min, not requiring help from another 
person, time in range as percent daily time spent in a blood glucose range of 70-180 mg/dL, percent time 
above range as daily time spent above 180 mg/dL and time below range as the percent time below 70 mg/dL 
target52. As part of the virtual transition of the ACT1ON study in response to Covid-19, HbA1c will provide a 
measure of long-term glycemic control.   
Adiposity: Percent body fat and visceral adipose volume (in³) are estimated with DXA.  
Weight status: Anthropometry follows standard procedures for determination of BMI. 
Dietary Intake: 24-hour dietary recalls (two unannounced days per data collection time point) are obtained by 
telephone by trained and certified interviewers from the UNC NIH/NIDDK Nutrition Obesity Research Center 
staff (P30DK056350; MPI Mayer-Davis) under the direction of Dr. Mayer-Davis (Diet Assessment Core 
Director), using the Nutrient Data System for Research (NDSR) software and the multiple pass interviewing 
method53,54. Habitual dietary patterns are also assessed using a validated food frequency questionnaire (NCI 
Diet History Questionnaire II http://riskfactor.cancer.gov/dhq2/webquest/). 
Acceptability of Experimental Diets: No instrument to systematically assess acceptability of experimental diets 
could be identified, so we developed a 5-item questionnaire for this purpose (Cronbach alpha = 0.89). 
Physical Activity: The validated55,56 Previous Day Physical Activity Recall (PDPAR) divides the day into half-
hour time blocks and queries the dominant activity and the approximate intensity of that activity for that period, 
categorized as ‘‘light,’’ ‘‘medium,’’ ‘‘hard,’’ or ‘‘very hard.’’ The PDPAR will be under the direction of the UNC 
NORC, to be administered concurrent with the 24-hour dietary recalls, as we have done previously.57  
Additional measures: Other measures being obtained include surveys to evaluate ingestive behavior and 
nutrition knowledge, diabetes quality of life and fear of hypoglycemia.  
Statistical Analyses and Power: The primary goal for the ACT1ON study is to evaluate the feasibility of the 
three diet interventions and estimate potential effect size and variance for a future randomized controlled trial. 
The ACT1ON study analyses also seek to assess the effect of experimental diets on adiposity (percent body 
fat and BMI) and glycemic control (time in range and HbA1c). Based on previous reports,58,59 the study has 
80% power to detect a 3.0 kg weight change and 1.3% HbA1c change.   
Data Management: An online data management system from the UNC Collaborative Studies Coordinating 
Center has been developed for the parent study and includes ancillary study data. The system includes online 
data collection and participant randomization tracking. The secure server environment is located within a 
hardened data center on UNC campus, and is governed by UNC information security guidelines. ACT1ON 
Progress: In response to the Covid-19 pandemic, the ACT1ON study was turned into a completely remote 
protocol for intervention and analysis. The ACT1ON study was designed with capacity for telehealth delivery 
with online data collection forms, home Bluetooth enabled scales provided to participants, and approval for 
remote RD visits. Following Covid-19, participants were provided CGM via mails as well as capillary tube 
collection kits for home HbA1c collection. Furthermore, instructions are now provided via zoom and home 
scales are being utilized for standardized weight measures. The primary changes to the study was the removal 
of DXA body composition measurement and the stopping of enrollment at prior to the original target of 84 
participants (Total (n=69), UNC-CH (n=40) Stanford (n=29)).  
2.2. Pilot Physical Activity Data Selection  
Description: Data collection for the physical activity pilot began at both UNC-CH and Stanford as part of 
remote data collection for the ACT1ON trial in June 2020. The goal of the physical activity pilot is to assess the 
role of varying amounts and intensities of physical activity on the primary outcomes of glycemic control and 
weight management.   
Inclusion/Exclusion Criteria: Any participant in the ACT1ON SMART pilot willing to provide data regarding 
their physical activity is invited to participate. Of the 69 participants of the ACT1ON study (UNC-CH=40, 
Stanford = 29) that will be recruited, we expect that 65 (94%) will participate in the physical activity portion of 
the protocol. Multiple observations will be obtained for participants over the 14-day wear time across multiple 
study visits for participants with greater than one measurement visit remaining. It is estimated  
Methods: Consent to participate in the Physical Activity Pilot is obtained remotely from participants as part of 
preparation for their next upcoming standardized measurement visit. Participants in the physical activity pilot 
are asked to wear a Garmin Vivosmart 4 Fitness Tracker and provide a session rate of perceived exertion 
(sRPE) rating with each bout of structured exercise during each 14-day data collection period, concurrent with 
CGM data collection. Session Rate of Perceived Exertion (sRPE) is assessed by participants utilizing a secure 
online survey containing a validated sRPE scale. The scale is made accessible to participants through a QR 
code printed on labels attached to a water bottle and keychain provided to the participants by the study site. 
Participants are asked to wait at least 30 minutes following exercise to assess their sRPE, but within 24 hours 
in accordance with previous studies which found that sRPE measures collected earlier than 30 minutes had an 
increased risk of bias by the last exercise done in the session, but were valid up to 24 hours following exercise. 
Participants also receive a daily email reminder during the 14-day data collection period that contains a link to 
the survey. 
Additional Measures:  
Garmin Vivosmart 4 Fitness Tracker: The Garmin Vivosmart 4 fitness tracker utilizes a built in Garmin 
Elevate™ Heart Rate monitor, altimeter, accelerometer, and Bluetooth® Smart and ANT+® technology to 
measure outcomes of interest, including heart rate (HR), step count, floors climbed, and energy expenditure 
(EE) and automatically syncs to a study Garmin Connect account. Extraction and overlaying of Garmin Data 
with CGM data will be performed by a pediatric endocrinologist in contract with the ACT1ON team.  
Heart Rate: Heart rate has been shown to have an almost linear relationship with VO2max at submaximal 
intensities and is one of the most common objective tools for the measurement of exercise intensity60. Heart 
rate is collected by the wrist-worn Garmin Vivosmart4 fitness tracker which has been shown to be validated as 
an accurate tool and possess an activity mode which has been shown to improve accuracy of heart rate during 
exercise61. Intense aerobic or anerobic exercise is characterized as exercise at ≥80% estimated VO2max 
equivalent to approximately 88% age-predicted HRmax62. 
Session Rate of Perceived Exertion (sRPE): sREP has been shown to be a valid, reliable, and practical tool 
for monitoring training load63–66. This method asks participants to assess the intensity of their workout with a 
single number rating between 0 – 10, with 0 being equivalent to complete rest and 10 being a maximal bout of 
exercise. Through incorporating both RPE and duration of exercise, this method can provide insight to the 
physical and psychological effort of exercise over the course of 14 days, as well as the total strain and 
monotony of training experienced by participants. sRPE data is recorded via a survey accessible to 
participants via a QR code provide to the participants with their study materials. Responses to sRPE surveys 
are stored and extracted from a secure database (REDCap). 
 
 
2.3. Statistical Considerations 
 
 
Significant effects in prior studies with comparable or smaller sample sizes 
Aim 1 and 3a.  Exercise Intensity and Risk of Hypoglycemia During and 4-Hours Following Exercise: In 7 adult 
men with T1D, high intensity interval training exercise resulted in significantly smaller decrease in blood 
glucose than continuous exercise (1.51 ± 0.92 vs. 3.00 ± 1.54 mmol.l-1, p = 0.024)28. Furthermore, In 11 adults 
with T1D, the addition of intermittent, high intensity work to continuous exercise resulted in significantly high 
nocturnal glucose levels, less post-exercise hypoglycemia (5.2 vs 1.5% of time spent with glucose <4.0 
mmol/L) and more post-exercise hyperglycemia (33.8 vs. 20.4% of time > 11.0 mmol ⁄ l) compared to 
continuous exercise alone18. 
 
Aim 2 and 3b. Protein Ingestion & Hypoglycemia During and 4-Hours Following Exercise:  In 33 children with 
T1D, consumption of a high protein meal had a protective effect on the development of hypoglycemia over 5 
hours (Odds Ratio 0.16, 95% CI 0.06 – 0.41)43.  
 
Statistical Analyses: 
Demographic, clinical, and design covariates (Baseline & 3-, 6-, & 9-month): Ns, means, and SDs will be 
computed for continuous variables (age and insulin dose per kg). Counts and percentages will be computed for 
categorical variables [sex, race/ethnicity, insulin regimen, site, and randomized diet (3-, 6-, and 9-months). 
Exposures and Outcomes (Table 2) 
3-, 6-, and 9-month Measurement Visits: Time in intense aerobic or anaerobic exercise, protein intake within 2 
hours of exercise, occurrence of hypoglycemia, time in range, time above range and time below range 
following exercise will be cross-sectionally analyzed for each measurement visit.  
  
Table 2. Proposed Study Variable Descriptions and Measurement Time Points 
AIMS 1 & 3a Measure(s) Description 3-mo 6-mo 9-mo 
   Exposure Time in Intense Aerobic 
& Anaerobic Exercise 
Exercise reaching a peak HR ≥88% of age-predicted 
heart rate max or a reported sRPE ≥8.  
X X X 
   Outcomes 




CGM-based glucose <70mg/dl for more than 10 min, 
not requiring help from another person, during exercise 
X X X 
Occurrence of 
hypoglycemia within 4 
hours following exercise 
CGM-based glucose <70mg/dl for more than 10 min, 
not requiring help from another person within 4 hours 
following exercise 
X X X 
   Outcomes 
   (AIM 3a) 
Time in range  % time spent in 70–180 mg/dl during and 24 hours 
following exercise 
X X X 
Time above range % time spent >180 mg/dl during and 24 hours following 
exercise 
X X X 
Time below range % time spent <70 mg/dl during and 24 hours following 
exercise 
X X X 
AIMs 2 & 3b Measure(s) Description 3-mo 6-mo 9-mo 
   Exposure Peri-Workout Protein 
Ingestion 
Consumption of a meal containing at least 25g protein 
within 2 hours before or following exercise. 
X X X 
Table 1:  Detectable effects (Partial R2) at 80% and 90% power, α = 0.05† 80% power 90% power 
Aim 1 & 3a. Cross-Sectional Time in Intense Aerobic or Anaerobic Exercise vs Risk of 
Hypoglycemia During and 4 Hours Following Exercise 0.10 0.13 
Aim 2 & 3b. Cross-sectional Peri-Workout Protein Intake vs Occurrence of Hypoglycemia During 
and 4 Hours Following Exercise  0.10 0.13 
Aim 3a. Cross Sectional Time in Intense Aerobic or Anaerobic Exercise vs Time in Range 24 
Hours Following Exercise 0.10 0.13 
Aim 3b. Cross Sectional Peri-Workout Protein Intake vs Time in Range 24 Hours Following 
Exercise 0.10 0.13 
†Effect sizes computed for partial R2 with G-Power software Version 3.1.9.7. 
   Outcomes 




CGM-based glucose <70mg/dl for more than 10 min, 
not requiring help from another person during exercise 
X X X 
Occurrence of 
hypoglycemia within 4 
hours following exercise 
CGM-based glucose <70mg/dl for more than 10 min, 
not requiring help from another person within 4 hours 
following exercise 
X X X 
   Outcomes                 
   (AIM 3b) 
Time in range  % time spent in 70–180 mg/dl during and 24 hours 
following exercise 
X X X 
Time above range % time spent >180 mg/dl during and 24 hours following 
exercise 
X X X 
Time below range % time spent <70 mg/dl during and 24 hours following 
exercise 
X X X 
   Potential 
confounders  
 
Demographic (all aims) Age, gender, race/ethnicity, clinic site X   
Clinical (all aims) Age at diagnosis, insulin regimen, randomized diet*  X   
Dietary (Aims 2 and 3b) Kcal, Fat and Carbohydrate Intake X X X 
Exercise Factors (Aims 
1 & 3a) 
Exercise duration X X X 
 
Inferential Analysis and Expected Outcomes: 
Linear mixed models that account for non-independence of observations due to repeated measures within 
individuals will be used to evaluate study hypotheses.  To account for confounding, we will include covariates 
in models if they alter effect estimates or standard error substantially (i.e., by > 10% of the unadjusted value). 
For all models, following calculation of unadjusted estimates (Model 1), we will explore confounding through 
adjustment for prespecified demographic (Model 2) and clinical (Model 3) covariates 
 
2.4 Challenges and Opportunities 
With current recruitment numbers we possess sufficient sample size to detect an effect for our primary 
outcomes, however, the Covid-19 pandemic has limited recruitment below originally intended targets. 
Furthermore, while the study has been adapted to be fully virtual, as participants manage the additional stress 
of Covid-19, retention of participants within the study may become more difficult. The results from this study, 
however, will provided further insight into the role of exercise intensity on the risk of hypoglycemia and time in 
range for young adults with T1D and would be the first study to assess the effects of protein timing around 
exercise on the these same outcomes. Such insights are needed to inform strategies for mitigating the risk of 
hypoglycemia during and following exercise for people with T1D that may help to empower individuals with 
T1D to achieve higher levels of physical activity.  
 
3. Summary The proposed aims and methods represent a rigorous and reproducible model for collecting pilot 
data on the relationship between exercise intensity and peri-workout protein intake on the risk of hypoglycemia 
and glycemic excursions following exercise in a weight management trial of young adults with T1D. 
Hypoglycemia and glycemic excursions following exercise remain a significant barrier to exercise for people 
with T1D. The results of the proposed study will advance our knowledge of the role of two potential factors that 
may help to mitigate the risk of hypoglycemia during and following exercise for those with T1D. Furthermore, 
the results of the proposed study will drive future research that may inform clinical practice guidelines and 
empower people with T1D to engage in greater levels of physical activity.  
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